Jane Street’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.4K Buy
+23,683
New +$65.1K ﹤0.01% 10740
2026
Q1
Sell
-1,488
Closed -$10.5K 12755
2025
Q4
$10.5K Buy
+1,488
New +$13.3K ﹤0.01% 10832
2025
Q3
Sell
-11,163
Closed -$258K 11601
2025
Q2
$258K Buy
+11,163
New +$312K ﹤0.01% 8117
2025
Q1
Sell
-129
Closed -$8.62K 10415
2024
Q4
$8.62K Sell
129
-132
-51% -$8.76K ﹤0.01% 9193
2024
Q3
$10.1K Sell
261
-187
-42% -$13K ﹤0.01% 9352
2024
Q2
$62.7K Sell
448
-1,225
-73% -$167K ﹤0.01% 8872
2024
Q1
$355K Buy
1,673
+964
+136% +$260K ﹤0.01% 7287
2023
Q4
$180K Buy
+709
New +$194K ﹤0.01% 8293
2023
Q3
Sell
-1,039
Closed -$47.1K 9252
2023
Q2
$47.1K Buy
+1,039
New +$79.7K ﹤0.01% 8222
2022
Q2
Sell
-532
Closed -$351K 10665
2022
Q1
$351K Buy
532
+297
+126% +$158K ﹤0.01% 8136
2021
Q4
$137K Buy
+235
New +$171K ﹤0.01% 9064
2021
Q3
Sell
-149
Closed -$59K 10587
2021
Q2
$59K Buy
+149
New +$48.6K ﹤0.01% 9464
2020
Q3
Sell
-158
Closed -$53K 7790
2020
Q2
$53K Buy
+158
New +$47.7K ﹤0.01% 6858

Other funds holding LNAI

Jane Street's LNAI Position: Q2 2026 in Review

Jane Street opened a new position in Lunai Bioworks (LNAI) in Q2 2026: 23,683 shares worth $77.4K. The stake represents ﹤0.01% of the portfolio and ranks #10740 among its holdings. This is a return to the name: Jane Street previously reported a position in LNAI as recently as Q4 2025.

Jane Street first reported a position in LNAI in Q2 2020 and has held it in 13 quarters since. The position peaked at $355K in Q1 2024. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Jane Street held 23,683 shares of Lunai Bioworks worth $77.4K as of Q2 2026.
  • Lunai Bioworks was a new Jane Street position in Q2 2026.
  • Lunai Bioworks made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10740 holding.
  • Jane Street first reported a position in Lunai Bioworks in Q2 2020 and has held it in 13 quarters since.
  • Jane Street's Lunai Bioworks position peaked at $355K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.